IQVIA™ Real-World Insights Bibliography

Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands
Author(s): Hanne van Ballegooijen 1, Lucas Goossens 2, Ralph H Bruin 3, Renée Michels 3, Marieke Krol 3
Affiliations(s): 1IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com. 2Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. 3IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands.
Publication(s):  1 IQVIA, Herikerbergweg 314, 1101 CT Amsterdam, The Netherlands. 2 Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands
BMC Health Services Research (2021) 21:227
PMID: 33712010 PMCID: PMC7953179 DOI: 10.1186/s12913-021-06240-7
Document Type(s): Article,
Countries: Netherlands ,
Click here for the abstract
C:
Y:
Health economics, Health status & patient reported outcomes, Immunology and Vaccination,
2021
  L:
A:
English
Observational study, Patient questionnaire, Population Based Study, Public Health, Quality of life, Survey research,
  Add to report
 
 
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany
Author(s): Rui Cai 1, Laetitia Gerlier 2, Martin Eichner 3 4, Markus Schwehm 5, Sankarasubramanian Rajaram 6, Joaquin Mould-Quevedo 7, Mark Lamotte 2
Affiliations(s): 1IQVIA Real World Solutions, Amsterdam, The Netherlands. 2IQVIA (Global HEOR), Zaventem, Belgium. 3Epimos GmbH, Dusslingen, Germany. 4Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. 5ExploSYS GmbH, Leinfelden-Echterdingen, Germany. 6Seqirus Vaccines Ltd, Maidenhead, UK. 7Seqirus Vaccines, Summit, NJ, USA
Publication(s):  Journal of Medical Economics 2021. https://doi.org/10.1080/13696998.2021.1908000
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Immunology and Vaccination,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Cost-Effectiveness of the CELL-Based Quadrivalent Versus the Standard Egg-Based Quadrivalent Influenza Vaccine in Germany. Results of a Dynamic Transmission Modelling Approach
Author(s): Cai R, Gerlier L, Eichner M, Schwehm M, Majaram S, Mould-Quevedo J, Lamotte M.
Affiliations(s): IQVIA HEOR Zaventem
Publication(s):  ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 105463
Document Type(s): Poster,
Countries: Germany,
C:
Y:
Immunology and Vaccination,
2020
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
REAL WORLD OUTCOMES OF ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY DURING 2016-2018 FLU SEASONS USING CLAIMS DATA
Author(s): Victoria Divino, Joaquin Mould-Quevedo, Miao Jiang, Mitchell DeKoven, Girishanthy Krishnarajah
Affiliations(s): IQVIA; Seqirus
Publication(s):  Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019
Document Type(s): Poster,
Countries: USA,
C:
Y:
Immunology and Vaccination, Respiratory disease,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
HOSPITALIZATION ENCOUNTERS FOLLOWING VACCINATION WITH ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY USING CLAIMS DATA
Author(s): Victoria Divino, Joaquin Mould-Quevedo, Mitchell DeKoven, Miao Jiang, Girishanthy Krishnarajah
Affiliations(s): IQVIA; Seqirus
Publication(s):  Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019
Document Type(s): Poster,
Countries: USA,
C:
Y:
Immunology and Vaccination, Respiratory disease,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
AN EARLY LOOK AT THE SECOND DOSE COMPLETION OF THE RECOMBINANT ZOSTER VACCINE (RZV) IN CANADIAN ADULTS ? A RETROSPECTIVE ANALYSIS
Author(s): Ashleigh McGirr1, Tara Bourgoin2, Michael Wortzman1, Brad Millson2, Shelly McNeil3
Affiliations(s): 1GSK, Mississauga, Canada, 2IQVIA, Ot tawa, Canada, 3Canadian Center for Vaccinology, IWK Heal th Centre and Nova Scotia Health Authority, Dalhousie University
Publication(s):  The CIRN Annual Meeting, 20 & 21 November 2019 - Toronto, Canada
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Immunology and Vaccination,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Lessons learned on enhanced passive safety surveillance of influenza vaccines.
Author(s): Khalife N., Almas M, Stam Morago, M, Negreiro F, Costa L, Projetto, S
Affiliations(s): 
Publication(s):  Pharmacoepidemiol & Drug Saf 2018;27(2):495
Document Type(s): Poster,
Countries: 
C:
Y:
Immunology and Vaccination,
2018
  L:
A:
English
  Add to report
 
 
The economic burden of CIDP in the United States: A case-control study.
Author(s): Divino V, Mallick R, DeKoven M, Krishnarajah G
Affiliations(s): IQVIA; CLS Behring
Publication(s):  Journal. PLoS One. 2018 Oct 23;13(10):e0206205.
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Immunology and Vaccination,
2018
  L:
A:
English
Cost of illness, Retrospective database analysis,
  Add to report
 
 
Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu® ) among adults in THIN database of electronic UK primary healthcare records
Author(s): Hall GC, Davies PTG, Karim MY, Haag MDM & O'Leary C
Affiliations(s): Seqirus
Publication(s):  Pharmacoepidemiology and Drug Safety
Document Type(s): Article,
Countries: UK,
C:
Y:
Immunology and Vaccination,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine.
Author(s): López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4.
Affiliations(s): 1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.
Publication(s):  Infect Agent Cancer. 2018 May 2;13:15.
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Health economics, Immunology and Vaccination, Infectious disease, Oncology,
2018
  L:
A:
English
Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research,
  Add to report
 
 
 1 of 8 Next Page Last Page